Cardiff Oncology, Inc.

CRDFCIK 0001213037 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Feb 24, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0207Δ-0.000693% similar+246/-189 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Jun 3, 20267.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits May 29, 20261.01 · Entry into a Material Definitive Agreeme May 19, 2026no items parsed May 14, 2026no items parsed Apr 9, 2026no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.06pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Cardiff Oncology, Inc.

Name	Roles	Filings
Erlander Mark	OfficerDirector	4
Markin Rodney S	Director	4
Smeal Tod	Officer	4
White Lale	Director	4
Brancaccio John P	Director	2

Showing 6-10 of 16

Per pagePrevPage 2 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Cardiff Oncology, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Pace Gary W	6	33%	+56.4%	-3.2%	+280.1%	-7.6%
2	Levine James E.	3	33%	-13.1%	-15.6%	+0.5%	-24.3%

All filings

55 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 28, 2026	Aggarwal Ajay Chief Operating Officer	Holdings only	-	-	-
Apr 16, 2026	Muntner Joshua B Chief Financial Officer	Holdings only	-	-	-
Apr 16, 2026	Muntner Joshua B Chief Financial Officer	Holdings only	-	-	-
Apr 16, 2026	Smeal Tod Chief Scientific Officer	Holdings only	-	-	-
Apr 2, 2026	Mohindru Mani Chief Executive Officer · Director	Holdings only	-	-	-

Showing 1-5 of 55

Per pagePage 1 of 11Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value